Table 2.
Study | Field Strength | Image type | Sample used for reliability | Intra- or inter-rater reliability? | Quantity measured | Reliability metric | Reliability value |
---|---|---|---|---|---|---|---|
Hagemeier et al. (2012)25 | 3T | Phase | 5 pwMS and 5 HCs | Intra (scan-rescan) | Per-subject number | ICC | 1 |
Per-subject volume | ICC | 0.999 | |||||
Kuchling et al. (2014)6* | 7T | T2*w | 10 representative cases (7 pwMS patients and 3 HCs) | Intra | Per-subject number | ICC as a two-way mixed test for average measures | 0.854 |
Inter | Per-subject number | ICC as a two-way mixed test for average measures | 0.796 | ||||
Sinnecker et al. (2016)35* | 7T | Phase | 10 randomly selected pwMS or pwNMOSD | Inter | Per-subject number | ICC as a 2-way mixed test of average measures | 0.96 |
Dal-Bianco et al. (2017)27, 28 | 7T | FLAIR-SWI | 15 rim or non-rim lesions segmented twice | Intra | Per-lesion volume | ICC | 0.998 |
Absinta et al. (2018)4* | 3T | Phase | 100 lesions from 20 pwMS (16 RRMS, 4 PMS), 5 lesions per pwMS | Inter | Per-lesion rim presence | Fleiss κ | 0.71 |
Intra | Per-lesion rim presence | Cohen’s κ | 0.77 | ||||
7T | Inter | Per-lesion rim presence | Cohen’s κ | 0.72 | |||
Intra | Per-lesion rim presence | Cohen’s κ | 0.77 | ||||
Barquero et al. (2020)39* | 3T | Phase | 124 pwMS (87 RRMS, 21 SPMS, 16 PPMS) | Inter | Per-lesion rim presence | Cohen’s κ | 0.73 |
Clarke et al. (2020)34* | 3T | SWI | 25 randomly-chosen scans (from 112 pwCIS and 35 non-MS) | Inter | Per-subject number | ICC (2-way mix model, single measures, absolute agreement) | 0.84 (0.64-0.93) (95% CI) |
Maggi et al. (2020)11* | 3T | Phase | 83 non-MS cases and 83 pwMS | Inter | Per-lesion rim presence | Cohen’s κ | 0.79 |
Dal-Bianco et al. (2021)27* | 7T | FLAIR-SWI | 15 randomly selected PRLs | Intra | Per-lesion volume | Dice | 0.92 ± 0.05 (mean ± s.d.) |
MP2RAGE | Intra | Per-lesion volume | Dice | 0.90 ± 0.02 (mean ± s.d.) | |||
Kolb et al. (2021)33* | 7T | T2*w phase | 110 randomly selected lesions | Intra | Per-lesion rim presence | Cohen’s κ | 0.96 |
Inter | Per-lesion rim presence | Kendall W | 0.88 | ||||
Maggi et al. (2021)40 | 3T | Unwrapped phase images | 118 pwMS (86 RRMS, 32 PMS) | Inter | Per-subject PRL category (0, 1-3, or 4+ PRLs) | Cohen’s κ | 0.83 |
Treaba et al. (2021)37 | 7T | Phase | 5 pwMS | Intra | Per-subject number | Lin’s concordance correlation coefficients | 0.99 |
Inter | Per-subject number | Lin’s concordance correlation coefficients | 0.98 | ||||
Altokhis et al. (2022)32 | 7T | SWI-filtered phase | 10 randomly selected pwCIS or pwMS | Intra | Per-subject PRL category (0, 1-3, or 4+ PRLs) | ICC | 0.95 |
Inter | Per-subject PRL category (0, 1-3, or 4+ PRLs) | ICC | 0.81 | ||||
Hemond et al. (2022) 8 | 1.5T | Filtered phase | 5 pwRRMS, 3pwSPMS, and 1 pwPPMS | Inter | Per-subject PRL presence | Cohen’s κ | 0.65 |
3T | Inter | Per-subject PRL presence | Cohen’s κ | 0.72 | |||
Intra | Per-subject PRL presence | Cohen’s κ | 0.70 | ||||
Huang et al. (2022)30* | 3T | High-pass-filtered phase | 2062 FLAIR-hyperintense no-enhancing lesions from 80 pwRRMS | Inter | Per-lesion rim presence | Cohen’s κ | 0.43 |
Inter | Per-lesion rim presence | Percent agreement | 75.8% | ||||
QSM | Inter | Per-lesion rim presence | Cohen’s κ | 0.62 | |||
Inter | Per-lesion rim presence | Percent agreement | 92.7% | ||||
Krajnc et al. (2022)41 | 3T | SWI | 75 pwMS | Inter | Per-lesion rim presence | Percent agreement | 98.7% |
Marcille et al. (2022)29* | 3T | QSM | 159 pwRRMS | Inter | Per-lesion rim presence | Bangdiwala’s B-statistics | 95.49% |
Cohen’s κ | 0.706 | ||||||
Cohen’s κ | 0.858 | ||||||
Fleiss κ | 0.71 | ||||||
Meaton et al. (2022)36 | 3T | SWI | 100 blocks (1/8 brain volume each) | Intra | Per-subject PRL presence | Cohen’s κ | 0.696 |
Inter | Per-subject PRL presence | Cohen’s κ | 0.827 | ||||
Micheletti et al. (2022)7 | 1.5T | Phase | 29 children (13 pwMS and 16 non-MS). 132 white matter lesions, 63 were in the MS group and 69 were in the non-MS group. | Inter | Per-lesion rim presence | Cohen’s κ | 0.75 |
Zhang et al. (2022)42* | 3T | QSM | 4,163 T2-FLAIR lesions from 172 pwMS | Inter | Per-lesion rim presence | Cohen’s κ | 0.59 |
Calvi et al. (2023)43* | 3T | SWI | 20 pwMS | Inter | Per-lesion rim presence | Cohen’s κ | 0.87 |
Krajnc et al. (2023)44 | 3T | SWI | 107 pwMS (97 RRMS, 10 SPMS) | Inter | Per-lesion rim presence | Percent agreement | 97.2% |
FLAIR – fluid-attenuated inversion recovery; HC – healthy control; ICC – intraclass correlation coefficient; pwNMOSD – people with neuromyelitis optica spectrum disorder; PRL – paramagnetic rim lesion; pwCIS – people with clinically isolated syndrome; pwMS – people with multiple sclerosis; pwPPMS – people with primary progressive multiple sclerosis; pwRRMS – people with relapsing-remitting multiple sclerosis; pwSPMS – people with secondary progressive multiple sclerosis; QSM – quantitative susceptibility mapping; RRMS – relapsing-remitting multiple sclerosis; SPMS – secondary progressive multiple sclerosis; SWI – susceptibility-weighted imaging.
Included in quantitative synthesis.